All women should get screened for breast cancer every other year starting at age 40. There is not enough evidence to decide whether to continue or stop screening in women 75 years or older and what more should be done to screen for breast cancer in women with dense breasts. To learn more...
The emergence of the racial disparity in US breast-cancer mortality. N Engl J Med. 2022;386(25):2349-2352. doi:10.1056/NEJMp2200244PubMedGoogle ScholarCrossref 25. Davis Lynn BC, Chernyavskiy P, Gierach GL, Rosenberg PS. Decreasing incidence of estrogen receptor-...
View chapterExplore book Informed and Shared Decision Making in Breast Screening Jolyn Hersch, ... Kirsten McCaffery, in Breast Cancer Screening, 2016 Plain Language Summary Breast cancer screening has been going on for many years now, and research suggests that most women in the community feel ...
Breast cancer screening in BC: What we should be proud of and how to make it even betterGordon, Paula B.British Columbia Medical Journal
Breast cancer screening by a combination of clinical breast examination (CBE) and mammography is effective in reducing mortality from breast cancer in all
Breast cancer risk for women with a false positive screening test. Br J Cancer 1988;211-2... P Peeters,M Mravunac,J Hendriks,... - 《British Journal of Cancer》 被引量: 91发表: 1988年 Screening women aged less than 50 years with a family history of breast cancer Family history is an...
Similarly, a woman who declines the invitation to screening needs to recognise that she runs a slightly higher risk of dying from breast cancer. 1.6 Conclusions and recommendations Breast screening extends lives. The panel's review of the evidence on benefit – the older RCTs, and those more ...
To identify protocols to screen, detect, prevent, and treat cancer therapy-induced bone loss resulting in osteoporosis in patients with breast cancer.Published books and articles.Normal bone remodeling is affected by hormonal stimulation. Breast cancer therapies target hormones that promote cancer cell ...
UK MRI Breast Screening Study Advisory Group (2000) Magnetic resonance imaging screening in women at genetic risk of breast cancer: Imaging and analysis protocol for the UK multicentre study. Magn Reson Imaging 18: 765–776 Warner E, Plewes DB, Shumak RS, Catzavelos GC, Di Prospero LS, Yaf...
Breast cancer is a global health issue affecting 2.3 million women per year, causing death in over 600,000. Mammography (and biopsy) is the gold standard for screening and diagnosis. Whilst effective, this test exposes individuals to radiation, has limitations to its sensitivity and specificity an...